Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome, June 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 103 articles:
HTML format


 

Single Articles

  1. SALEEM MM, Masood S, Rahmatullah MM, Ayesha Imdad I, et al
    Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome.
    Cureus. 2025;17:e83084.
    PubMed    
    Abstract available

  2. WANG YW, Li QY, Liu LF, Tan X, et al
    Long-term exposure to constant light disrupts intestinal stem cells through sympathoexcitation-induced Wnt5a signaling inhibition.
    Gastroenterol Rep (Oxf). 2025;13:goaf031.
    PubMed    
    Abstract available

  3. LATERZA L, Cremon C, Coppola G, Settanni CR, et al
    Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial.
    Nutrients. 2025;17:1708.
    PubMed    
    Abstract available

  4. YAO Q, Zhang W, Wang Y, Shi L, et al
    Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating Mast Cell Hyperactivation.
    Nutrients. 2025;17:1670.
    PubMed    
    Abstract available

  5. RESTANI P, Di Lorenzo C, Antoce AO, Araujo M, et al
    Moderate Wine Consumption and Gastrointestinal Diseases.
    Nutrients. 2025;17:1608.
    PubMed    
    Abstract available

  6. DI PIERRO F, Ficuccilli F, Tessieri L, Menasci F, et al
    Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study.
    Microorganisms. 2025;13:1139.
    PubMed    
    Abstract available

  7. HIRATA M, Fornari Laurindo L, Dogani Rodrigues V, Cristina Castilho Caracio F, et al
    Investigating the Health Potential of Mentha Species Against Gastrointestinal Disorders-A Systematic Review of Clinical Evidence.
    Pharmaceuticals (Basel). 2025;18:693.
    PubMed    
    Abstract available

  8. SZEKELY AB, Nseir M, Roth B, Ohlsson B, et al
    Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome.
    Int J Mol Sci. 2025;26:4607.
    PubMed    
    Abstract available

  9. NIU J, Zhang G, Ning W, Liu H, et al
    The causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study.
    Int J Surg. 2025 May 26. doi: 10.1097/JS9.0000000000002457.
    PubMed    
    Abstract available

  10. LIU J, Cheng K, Lu Y, Cabral H, et al
    Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study.
    Diseases. 2025;13:161.
    PubMed    
    Abstract available

  11. KIM SH, Kang W, Kim M, Hong S, et al
    Temple stay diet and its impact on gut microbiome and irritable bowel syndrome: a prospective cohort study.
    Food Funct. 2025 May 27. doi: 10.1039/d4fo06143.
    PubMed    
    Abstract available

  12. RETTURA F, Lambiase C, Tedeschi R, Grosso A, et al
    Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?
    Front Pharmacol. 2025;16:1538791.
    PubMed    
    Abstract available

  13. MANNING LP, Tuck CJ, Biesiekierski JR
    Predicting response to the low FODMAP diet in irritable bowel syndrome: Current evidence and clinical considerations.
    Asia Pac J Clin Nutr. 2025;34:373-385.
    PubMed    
    Abstract available

  14. CHERNOGOROVA MV, Medvedeva EA, Yurenev GL, Maryin GG, et al
    [Small intestinal bacterial overgrowth in gastrointestinal diseases - a consequence or a cause of progression?].
    Vopr Pitan. 2025;94:5-17.
    PubMed    
    Abstract available

  15. PASCUAL-MATO M, Garate Vinas G, Munoz San Martin M, Gonzalez-Quintanilla V, et al
    Calcitonin gene-related peptide (CGRP) in the pathophysiology of gastrointestinal disorders - A key mediator in the gut-brain axis.
    Rev Esp Enferm Dig. 2025 May 26. doi: 10.17235/reed.2025.11310/2025.
    PubMed    
    Abstract available

  16. ALI A, Shah A, Amina A, Ruddock-Scott ZA, et al
    Prevalence of Irritable Bowel Syndrome Symptoms and Associated Risk Factors Among Medical Students.
    Cureus. 2025;17:e82900.
    PubMed    
    Abstract available

  17. ZVOLENSKY MJ, Smit T, Wein PY, Bakhshaie J, et al
    Gastrointestinal-specific anxiety and smoking abstinence expectancies among persons with irritable bowel syndrome.
    J Behav Med. 2025 May 26. doi: 10.1007/s10865-025-00576.
    PubMed    
    Abstract available

  18. SHUDT C, Smith S, Bortsov A, Parr K, et al
    Vestibulodynia Presentation is Differentiated by the Presence of Additional Chronic Primary Pain Conditions.
    J Pain. 2025 May 22:105450. doi: 10.1016/j.jpain.2025.105450.
    PubMed    
    Abstract available

  19. LIN H, Lv Y, Liu H, Lin Z, et al
    Baicalein alleviates chronic acute stress-induced irritable bowel syndrome-like symptoms in rats via modulating the ODC1/NF-kappaB pathway and oxidative stress.
    Biochem Biophys Res Commun. 2025;771:152058.
    PubMed    
    Abstract available

  20. LAKHAN SE
    Postmarket Safety Surveillance of FDA-Cleared Prescription Digital Therapeutics Using the Manufacturer and User Facility Device Experience (MAUDE) Database: A Pharmacovigilance Study.
    Cureus. 2025;17:e85343.
    PubMed    
    Abstract available

  21. AMIEVA-BALMORI M, Martinez-Perez GP, Francisco MR, Triana-Romero A, et al
    Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?
    Rev Gastroenterol Mex (Engl Ed). 2025 Jun 3:S2255-534X(25)00041.
    PubMed    
    Abstract available

  22. BERTUCCIOLI A, Sisti D, Lazzerini N, Palazzi CM, et al
    Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
    Front Med (Lausanne). 2025;12:1604319.
    PubMed    
    Abstract available

  23. JIANG S, Xu K, Chen X
    Identifying modifiable factors and their causal effects on osteoporosis risk.
    Sci Rep. 2025;15:19472.
    PubMed    
    Abstract available

  24. JO YW, Min JH, Kwon JW, Her Y, et al
    Rosacea and Its Potential Role in the Development of Irritable Bowel Syndrome: Insights From the Korean National Health Insurance Service-National Sample Cohort.
    J Korean Med Sci. 2025;40:e97.
    PubMed    
    Abstract available

  25. BAR-EL L, Veisman I, Simons M, Delpra C, et al
    Gut feeling: understanding the endometriosis-digestive link to enhance patient care and symptom control.
    Curr Opin Obstet Gynecol. 2025 May 8. doi: 10.1097/GCO.0000000000001041.
    PubMed    
    Abstract available

  26. NG RWY, Chen Z, Yang L, Wong OWH, et al
    Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis.
    Sci Rep. 2025;15:19278.
    PubMed    
    Abstract available

  27. XUE X, Hu J, Pei W, Mao T, et al
    Single-cell RNA-seq reveals the immune profile changes in patients with diarrhoeal-irritable bowel syndrome.
    Biochim Biophys Acta Mol Basis Dis. 2025 May 31:167945.
    PubMed    
    Abstract available

  28. EL DAIBANI A, Burgess G, Rysztak L, Jutkiewicz E, et al
    Delta opioid receptors: Overlooked outlier or the next big thing.
    Curr Opin Pharmacol. 2025;83:102528.
    PubMed    
    Abstract available

  29. WALZ KC, Suchodolski JS, Werner M, Grimm F, et al
    Long-Term Follow-Up After Acute Gastroenteritis Caused by Giardia Infection in Juvenile Dogs.
    J Vet Intern Med. 2025;39:e70123.
    PubMed    
    Abstract available

  30. WAN Y, Cao C, Zeng W
    The sympathetic neurons in the gut: Perspectives on metabolic and immune health and diseases.
    Curr Opin Neurobiol. 2025;93:103051.
    PubMed    
    Abstract available

  31. MORALES PS, Wijeyesekera A, Robertson MD, Kennedy J, et al
    A focus group study to assess perspectives of patients with irritable bowel syndrome on human milk oligosaccharides and lifestyle insights.
    Eur J Nutr. 2025;64:196.
    PubMed    
    Abstract available

  32. RUAN J, Zhu J, Li K, Wang Z, et al
    Effect of Electroacupuncture on Intestinal Mucosal Barrier in IBS-D Rats: Analysis Based on RNA-seq.
    Comb Chem High Throughput Screen. 2025.
    PubMed    
    Abstract available

  33. TULLY PJ, Cosh S, Wittert G, Martin S, et al
    Insight inTo Stress and POOping on Work TIME (ITS POO TIME): Protocol for a Web-Based, Cross-Sectional Study.
    JMIR Res Protoc. 2025;14:e58655.
    PubMed    
    Abstract available

  34. HUANG Y, Cai L, Liu J, Yang R, et al
    Is there a bidirectional relationship between allergic rhinitis and irritable bowel syndrome? A meta-analysis.
    J Glob Health. 2025;15:04155.
    PubMed    
    Abstract available

  35. SMOLINSKA S, Popescu FD, Zemelka-Wiacek M
    A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity.
    J Clin Med. 2025;14:3673.
    PubMed    
    Abstract available

  36. HUANG G, Cai L, Guo J, Zhu R, et al
    Antibiotic-related dysbiosis of gut microbiota in healthy volunteers: a comparative study of ceftazidime-avibactam, piperacillin-tazobactam, and ceftriaxone.
    Eur J Clin Microbiol Infect Dis. 2025 Jun 12. doi: 10.1007/s10096-025-05184.
    PubMed    
    Abstract available

  37. ANDREWS MB, Adler DG
    Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, plecanatide, and Tenapanor: analysis of the FDA adverse event reporting system (FAERS) database.
    Expert Opin Drug Saf. 2025 Jun 12. doi: 10.1080/14740338.2025.2519833.
    PubMed    
    Abstract available

  38. LIU X, Lin R, Li X, He M, et al
    Association of maternal smoking, breastfeeding, and multiple birth with irritable bowel syndrome in older adults: a UK Biobank cohort study.
    Gastroenterol Rep (Oxf). 2025;13:goaf042.
    PubMed    
    Abstract available

  39. VENKATARAMAN A, Figueroa EE, Castro J, Navarro FMC, et al
    A Cellular Basis for Heightened Gut Sensitivity in Females.
    bioRxiv [Preprint]. 2025 May 28:2025.05.23.654927.
    PubMed    
    Abstract available

  40. SJOBLOM K, Frankenstein K, Klintwall L, Nilbrink J, et al
    Online Transdiagnostic Emotion Regulation Treatment for Adolescents With Mental Health Problems: A Randomized Clinical Trial.
    JAMA Netw Open. 2025;8:e2514871.
    PubMed    
    Abstract available

  41. GOTHLIN H, Hasseus B, Sjoberg K, Bankvall M, et al
    Manifestations of the oral mucosa and salivary glands in irritable bowel syndrome and microscopic colitis - A systematic review.
    Acta Odontol Scand. 2025;84:349-362.
    PubMed    
    Abstract available

  42. XIA Y, Liang C, Luo H, Zhang Y, et al
    Therapeutic Potential of Flavonoids and Flavonoid-Rich Compounds in Irritable Bowel Syndrome.
    Drug Des Devel Ther. 2025;19:4895-4910.
    PubMed    
    Abstract available

  43. VON MUHLENBROCK C, Nunez P, Herrera K, Pacheco N, et al
    Fecal microbiota transplantation through colonoscopy for the management of severe refractory irritable bowel syndrome: Preliminary results.
    Rev Gastroenterol Mex (Engl Ed). 2025 Jun 9:S2255-534X(25)00064.
    PubMed    
    Abstract available

  44. AL-BELTAGI M, Saeed NK, Bediwy AS, Elbeltagi R, et al
    Breaking the cycle: Psychological and social dimensions of pediatric functional gastrointestinal disorders.
    World J Clin Pediatr. 2025;14:103323.
    PubMed    
    Abstract available

  45. LOVDAHL J, Blomqvist-Storm M, Palsson OS, Ringstrom G, et al
    Nurse-Administered Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Two-Year Follow-Up Study.
    United European Gastroenterol J. 2025 Jun 9. doi: 10.1002/ueg2.70060.
    PubMed    
    Abstract available

  46. MATIJASIC M, Baresic A, Cipcic Paljetak H, Peric M, et al
    Serum proteins and faecal microbiota as potential biomarkers in newly diagnosed, treatment-naive inflammatory bowel disease and irritable bowel syndrome patients.
    J Mol Med (Berl). 2025 Jun 7. doi: 10.1007/s00109-025-02558.
    PubMed    
    Abstract available

  47. YAN F, Huang H, Li Y
    Mood instability and 22 gastrointestinal disorders: investigating the causal relationships and the mediating factors by Mendelian randomization analysis.
    J Affect Disord. 2025;388:119591.
    PubMed    
    Abstract available

  48. NAVEED M, Choudary MAA, Aziz T, Makhdoom SI, et al
    Using novel approaches to conjugate peptides of Macrotermes bellicosus and Curcuma longa for targeted intervention of irritable bowl diseases caused by tumor necrosis factor superfamily member 15 (TNFSF15).
    Mol Immunol. 2025;183:286-295.
    PubMed    
    Abstract available

  49. AL-BELTAGI M, Saeed NK, Bediwy AS, El-Sawaf Y, et al
    Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity.
    World J Gastroenterol. 2025;31:106835.
    PubMed    
    Abstract available

  50. GAO Y, Gong X, Qi J, Guo P, et al
    Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.
    Am J Transl Res. 2025;17:3333-3344.
    PubMed    
    Abstract available

  51. HAO L, Ge Y, Chen Z, Yuan D, et al
    Interaction Between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential.
    J Innate Immun. 2025 Jun 18:1-17. doi: 10.1159/000546972.
    PubMed    
    Abstract available

  52. ROJAS DL, Torres-Soto NY, Martin-Estal I, de Ita JR, et al
    Impact of benevolent childhood experiences on mental and physical health in Mexican population.
    Child Abuse Negl. 2025;167:107559.
    PubMed    
    Abstract available

  53. FRIAS J, Martins M, Peixoto A, Macedo G, et al
    Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders.
    GE Port J Gastroenterol. 2025 Apr 21:1-15. doi: 10.1159/000545926.
    PubMed    
    Abstract available

  54. LIU Q, Shi Z, Jiang Y, Zhang T, et al
    Efficacy and safety of Chinese botanical drug Si Shen Wan in irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.
    Front Pharmacol. 2025;16:1534904.
    PubMed    
    Abstract available

  55. XU X, Huang Y, Ma Z, Liu Z, et al
    Exploration of TCM Comprehensive Treatment of Irritable Bowel Syndrome Based on Pathophysiological Mechanism.
    Int J Gen Med. 2025;18:3075-3091.
    PubMed    
    Abstract available

  56. RUSZKOWSKI J, Kachlik Z, Walaszek M, Storman D, et al
    Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review.
    J Transl Med. 2025;23:662.
    PubMed    
    Abstract available

  57. MCKERCHAR S, Mire EL, Badcock N, Jones M, et al
    No Evidence for Unconscious Attentional Bias in People With Clinically Significant Symptoms of Functional Gastrointestinal Disorders: A Study Using the Emerging Electroencephalographic Paradigm of Fast Periodic Visual Stimulation.
    Neurogastroenterol Motil. 2025 Jun 16:e70099. doi: 10.1111/nmo.70099.
    PubMed    
    Abstract available

  58. YANG NN, Xie XX, Yan WL, Liu YD, et al
    The Autonomic Nervous System in Acupuncture for Gastrointestinal Dysmotility: From Anatomical Insights to Clinical Medicine.
    Int J Med Sci. 2025;22:2620-2636.
    PubMed    
    Abstract available

  59. BLANKENBERGER A, Lesmana E, Yang L, Comba IY, et al
    Longitudinal Changes in the Gut Microbiome of Patients With Irritable Bowel Syndrome After Campylobacter Infection are Associated With Proteolytic Activity.
    Gastro Hep Adv. 2025;4:100683.
    PubMed    


  60. WANG YF, Yao ZY, Xiao Y, Wang XQ, et al
    [A cross-sectional questionnaire survey on the prevalence and risk factors of 4 major functional gastrointestinal disorders among children in Shanghai].
    Zhonghua Er Ke Za Zhi. 2025;63:747-753.
    PubMed    
    Abstract available

  61. ISHIOH M, Nozu T, Miyagishi S, Funayama T, et al
    Carnosine improves colonic hyperpermeability through the brain histamine H1 receptor, basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
    Eur J Pharmacol. 2025;1002:177844.
    PubMed    
    Abstract available

  62. BOSI A, Banfi D, Capo JD, Ponti A, et al
    Sex-dependent alteration of the enteric neuromuscular function after antibiotic-induced dysbiosis in juvenile mice and effect of Lactocaseibacillus rhamnosus GG.
    Biomed Pharmacother. 2025;189:118263.
    PubMed    
    Abstract available

  63. CUENDE-ESTEVEZ M, Hussein H, Pia F, Backaert W, et al
    Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jun 14:e70108. doi: 10.1111/nmo.70108.
    PubMed    
    Abstract available

  64. ZHANG L, Song Z, Huang X, Jiang B, et al
    Research progress on the regulation of interstitial cell of Cajal autophagy and apoptosis crosstalk by traditional Chinese medicine in gastrointestinal motility disorders.
    J Ethnopharmacol. 2025 Jun 11:120128. doi: 10.1016/j.jep.2025.120128.
    PubMed    
    Abstract available

  65. DENDRINOS E, Kim H, Hubik D, Green J, et al
    Clinical outcomes of patients seen by psychiatrists in a multidisciplinary clinic for disorders of gut-brain interaction.
    Intern Med J. 2025 Jun 27. doi: 10.1111/imj.70134.
    PubMed    
    Abstract available

  66. ZHAO P, Han Q, Qiu X
    Comments to the Editor: opinions on "Causal effects of primary biliary cholangitis on irritable bowel syndrome: a Mendelian randomization study".
    Int J Surg. 2025 Jun 27. doi: 10.1097/JS9.0000000000002759.
    PubMed    


  67. LI E, Wang J, Guo B, Zhang W, et al
    Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial.
    Front Cell Infect Microbiol. 2025;15:1616066.
    PubMed    
    Abstract available

  68. FENNESSY A, Doyle M, Boland A, Bourke R, et al
    Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial).
    World J Gastrointest Pharmacol Ther. 2025;16:101268.
    PubMed    
    Abstract available

  69. BHAGAVATHULA AS, Al Qady AM, Aldhaleei WA
    Diagnostic accuracy and quality of artificial intelligence models in irritable bowel syndrome: A systematic review.
    World J Gastroenterol. 2025;31:106836.
    PubMed    
    Abstract available

  70. CHENG P, Jia R, Jin B, Zhou F, et al
    IBS May Have a Causal Effect on Increased Tryptophan Metabolites Levels: Insights from a Bidirectional Two-Sample Mendelian Randomization Study.
    Int J Tryptophan Res. 2025;18:11786469251327399.
    PubMed    
    Abstract available

  71. KUZMIN L, Kubiak K, Lange E
    Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders-A Systematic Review of Randomized Controlled Trials.
    Nutrients. 2025;17:2045.
    PubMed    
    Abstract available

  72. BUTT MF, Scotto D, Gilmartin CGS, Dhali A, et al
    A Medical Student Curriculum on Functional Medical Disorders.
    Clin Teach. 2025;22:e70117.
    PubMed    
    Abstract available

  73. JANEV A, Zupancic D, Veranic P, Kuret T, et al
    Oxidative stress and chronic inflammation as partners in crime in interstitial cystitis/bladder pain syndrome.
    J Innate Immun. 2025 Jun 26:1-39. doi: 10.1159/000546901.
    PubMed    
    Abstract available

  74. CLARK DA, Moayyedi P
    Fecal CD200 as a Measure of Immunosuppressive CD200L and Proinflammatory CD200S at the Feto-Maternal Interface.
    Am J Reprod Immunol. 2025;94:e70120.
    PubMed    
    Abstract available

  75. ALIPOUR-VAEZI M, McNamara RS, Rukstalis MR, Gentry EC, et al
    Comparative Risk of Developing Interstitial Cystitis With Childhood Gastrointestinal, Urological, Autoimmune, or Psychiatric Disorders.
    Neurourol Urodyn. 2025 Jun 25. doi: 10.1002/nau.70104.
    PubMed    
    Abstract available

  76. WANG X, Sun Z, Xue H, An R, et al
    Artificial Intelligence Applications to Personalized Dietary Recommendations: A Systematic Review.
    Healthcare (Basel). 2025;13:1417.
    PubMed    
    Abstract available

  77. LEVINE J, Islam RK, Mo L, Kim BS, et al
    Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study.
    Allergy. 2025 Jun 25. doi: 10.1111/all.16637.
    PubMed    


  78. LIN DK, Chang HC
    Association of Atopic Dermatitis or Allergic Rhinitis With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Allergy. 2025 Jun 25. doi: 10.1111/all.16630.
    PubMed    


  79. STASI C, Bellini M
    Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies.
    Pathogens. 2025;14:555.
    PubMed    
    Abstract available

  80. SANTONICOLA A, Moscato P, Soldaini C, Loi G, et al
    The effect of medical cannabis on gastrointestinal symptoms in fibromyalgia and disorders of gut-brain interaction: a patient?centred real?world observational study.
    Clin Exp Rheumatol. 2025;43:1074-1081.
    PubMed    
    Abstract available

  81. MUKHOPADHYAY S, Ulaganathan N, Dumpuri P, Aich P, et al
    Integrative AI-Based Approaches to Connect the Multiome to Use Microbiome-Metabolome Interactive Outcome as Precision Medicine.
    Methods Mol Biol. 2025;2952:15-37.
    PubMed    
    Abstract available

  82. SUN Z, Jiang L, Xing Y, Luo F, et al
    Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial.
    BMJ Open. 2025;15:e099793.
    PubMed    
    Abstract available

  83. JAAFARI H, Houghton LA, West RM, Shuweihdi F, et al
    Dietary patterns are associated with variations in the global prevalence and severity of Rome IV Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2025 Jun 21:S1542-3565(25)00523.
    PubMed    
    Abstract available

  84. ZHANG C, Liu L, Wang Z, Jiang J, et al
    Commentary on "The causal effects of primary biliary cholangitis on irritable bowel syndrome: a Mendelian randomization study".
    Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002793.
    PubMed    


  85. WU X, Chen G, Yang L, Lv Z, et al
    Comprehensive antibiotic resistome comparison of Escherichia coli from irritable bowel syndrome and ulcerative colitis.
    Curr Res Microb Sci. 2025;8:100398.
    PubMed    
    Abstract available

  86. SABATE JM
    [Irritable bowel syndrome].
    Rev Prat. 2025;75:408-413.
    PubMed    
    Abstract available

  87. FENG Y, Zhou C, He Y, Wu Y, et al
    Shugan Decoction Ameliorated WAS-Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4-PGE(2) Signaling.
    Neurogastroenterol Motil. 2025 Jun 22:e70104. doi: 10.1111/nmo.70104.
    PubMed    
    Abstract available

  88. MORALES-GUZMAN AS, Alarcon-Aguilar A, Luna-Lopez A, Santana-Vargas AD, et al
    Abnormal Homeostasis in the Redox State and Related Signaling Pathways, in Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jun 22:e70097. doi: 10.1111/nmo.70097.
    PubMed    
    Abstract available

  89. PALANIVELU L, Chen YY, Liang YW, Li SJ, et al
    Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats.
    Neuroimage. 2025;317:121344.
    PubMed    
    Abstract available

  90. AIHARA Y, Ito Y, Takeshita E, Oba M, et al
    Prevalence and management of gastrointestinal complications in Duchenne muscular dystrophy: A retrospective cohort study.
    Brain Dev. 2025;47:104379.
    PubMed    
    Abstract available

  91. ZENG X, He W, Chen X, Luo H, et al
    Letter to the editor: a commentary on "The causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study".
    Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002690.
    PubMed    


  92. KARRENTO K, Lu PL, Chumpitazi BP
    Little Patients Big Discoveries: Potential Pediatric to Adult Neurogastroenterology Translation.
    Am J Gastroenterol. 2025 Jun 6. doi: 10.14309/ajg.0000000000003579.
    PubMed    
    Abstract available

  93. BUSAM JA, Batta N, Shah ED, Joo L, et al
    The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003572.
    PubMed    
    Abstract available

  94. AWAD DC, Hubner DM
    The impact of violence and trauma on patient care: What the gastroenterologist needs to know.
    Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003587.
    PubMed    


  95. SHIHA MG, Schiepatti A, Manza F, Maimaris S, et al
    Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis.
    Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003586.
    PubMed    
    Abstract available

  96. RAO SSC
    Fructose and Lactose Malabsorption or Intolerance or Hypersensitivity: Which Triggers Symptoms and Why?
    Am J Gastroenterol. 2025 Jun 26. doi: 10.14309/ajg.0000000000003577.
    PubMed    


  97. TURSI A, Marinoni B, Privitera AC, Privitera L, et al
    STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical Efficacy.
    Dig Dis. 2025;43:266-272.
    PubMed    
    Abstract available

  98. HIRAMOTO BA, Lee S, Chan WW
    Looking Beyond the Barrier for Fecal Incontinence: The Brain-Gut Axis and Central Neurosensory Processes as Treatment Targets.
    Dig Dis Sci. 2025 Jun 12. doi: 10.1007/s10620-025-09114.
    PubMed    


  99. YANG JW, Qi LY, Yan SY, She YF, et al
    Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): a multi-centre randomized controlled trial.
    Gastroenterology. 2025 May 27:S0016-5085(25)00826.
    PubMed    
    Abstract available

  100. TKALCIC M, Toncic M, Pletikosic Toncic S, Troskot Peric R, et al
    Attentional Biases in Irritable Bowel Syndrome Patients: The Role of Interoception and Anxiety.
    J Clin Gastroenterol. 2025 Jun 2. doi: 10.1097/MCG.0000000000002200.
    PubMed    
    Abstract available

  101. GROEN J, Gordon M, Chogle A, Benninga M, et al
    ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years.
    J Pediatr Gastroenterol Nutr. 2025 May 30. doi: 10.1002/jpn3.70070.
    PubMed    
    Abstract available

  102. HU J, Zhang Y, Liu C, Gkaravella A, et al
    Effects of microbiota-based interventions on depression and anxiety in children and adolescents-A systematic review.
    J Pediatr Gastroenterol Nutr. 2025 May 26. doi: 10.1002/jpn3.70092.
    PubMed    
    Abstract available

  103. SANDBERG-JANZON A, Karling P
    Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study.
    Scand J Gastroenterol. 2025 May 29:1-8. doi: 10.1080/00365521.2025.2512368.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;